Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219439 · ClinicalTrials.gov registry record
Evaluation of Discarded Laboratory Pathological Specimens and Media
A clinical trial of Serum and Non-viable Oocytes, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT01219439 is a study of Serum and Non-viable Oocytes that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01219439, a study of Serum and Non-viable Oocytes, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers propose to investigate the causes, incidence, and time-related events of chromosomal and physiologic abnormalities as they relate to patient diagnosis, fertility drugs utilized, and in vitro laboratory culture conditions.
Conditions Studied
Study Locations (1)
New Jersey
- Reproductive Medicine Assoicates of New Jersey - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2007-07 |
| Est. Completion | 2022-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01219439
The ClinicalTrials.gov registry entry for NCT01219439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Serum appearing as the primary indexed condition, and to 0 interventions.
NCT01219439 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT01219439 about?
NCT01219439 is a clinical study titled "Evaluation of Discarded Laboratory Pathological Specimens and Media". The researchers propose to investigate the causes, incidence, and time-related events of chromosomal and physiologic abnormalities as they relate to patient diagnosis, fertility drugs utilized, and in vitro laboratory culture conditions.
What is the current status of trial NCT01219439?
This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2007-07. Estimated completion is 2022-12.
What conditions does trial NCT01219439 study?
This clinical trial studies the following conditions: Serum, Non-viable Oocytes, Extra Spermatozoa, Seminal Fluid, Granulosa Cells.
Who is sponsoring clinical trial NCT01219439?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01219439 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Serum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.